Study of the Safety and Efficacy of the Subunit Recombinant Tuberculosis Vaccine GamTBvac
Clinical trial NCT04975737 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT04975737
- Sponsor
- Gamaleya Research Institute of Epidemiology and Microbiology, Health Ministry of the Russian Federation
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2022-01-20
- Primary completion
- 2026-12-01
- Enrollment
- 9500
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.